Article Sidebar

pdf
Date Published: 26/12/2025
Abstract Views: 103
Views pdf: 45
DOI: https://doi.org/10.51298/vmj.v557i1.16580
Issue
Vol. 557 No. 1 (2025)
Section
Các bài báo
How to Cite
Đinh, T. Y., Phạm, N. Đức, & Nguyễn, T. U. (2025). DYSLIPIDEMIA AND SOME FACTORS ASSOCIATED WITH PSORIASIS AT HANOI DERMATOLOGY HOSPITAL IN 2024. Vietnam Medical Journal, 557(1). https://doi.org/10.51298/vmj.v557i1.16580

DYSLIPIDEMIA AND SOME FACTORS ASSOCIATED WITH PSORIASIS AT HANOI DERMATOLOGY HOSPITAL IN 2024

Thị Yến Đinh, Ngọc Đức Phạm, Thu Uyên Nguyễn

Main Article Content

Abstract

Objective: To determine the prevalence of dyslipidemia and some related factors in patients with psoriasis. Subjects and Methods: Cross-sectional study was conducted on 112 patients with a confirmed diagnosis of psoriasis at Hanoi Dermatology Hospital. Data were collected at the hospital. Blood lipid parameters were analyzed in relation to clinical characteristics. Results: The mean age was 40.2 ± 13.0 years, with males accounting for 37.5%. Plaque psoriasis was the most common type (85.6%), and the most patients had disease duration over 12 months. The prevalence of dyslipidemia was 55.4%. The most common abnormalities were elevated total cholesterol (24.1%) and triglycerides (23.2%). Triglyceride levels were significantly higher in males, while other lipid indices showed no significant differences. The prevalence of alcohol use was higher in men than in women. Conclusion: Dyslipidemia is common in patients with psoriasis (>50%). Controlling risk factors, particularly alcohol consumption, plays an important role.

Article Details

Keywords

Psoriasis, dyslipidemia.

References

Golpour M., Hosseini S.H., Khademloo M., et al. (2012). Depression and Anxiety Disorders among Patients with Psoriasis: A Hospital-Based Case-Control Study. Dermatol Res Pract, 2012, 381905.
2. Bộ môn Da liễu - Trường Đại học Y Hà Nội (2017). Bệnh vảy nến. Bệnh học da liễu tập 1. Nhà xuất bản y học, 103–113.
3. Wu Y, Mills D, Bala M (2008). Psoriasis: cardiovascular risk factors and other disease comorbidities. JDD 7 (4): 373-377.
4. Thompson, G., Morrell, J., & Morrell, J. (2006). Dyslipidaemia in Clinical Practice (2nd ed.).
5. Salihbegovic EM, Hadzigrahic N, Suljagic E et al (2015). Psoriasis and Dyslipidemia. Mater Sociomed; 27(1): 15-17.
6. Daudén E, Castañeda S, Suárez C et al (2013). Clinical practice guideline for an integrated approach to comorbidity in patients with psoriasis. J Eur Acad Dermatol Venereol 27, 1387-1404.
7. Jamil A, Ahsan U, Malik LM et al (2014). Frequency of dyslipidemia in patients with psoriasis. Journal of Pakistan Association of Dermatologists 24 (4):307-311.
8. Châu Ngọc Hoa (2005). Lipid và lipoprotein ở người bình thường. Y Học TP. Hồ Chí Minh, Tập 9, phụ bản của số 1: 40-42.
9. Mallbris L, Granath F, Hamsten A, et al (2006). Psoriasis is associated with lipid abnormalities at the onset of skin disease. J Am Acad Dermatol.;54:614-21.